The global Marijuana Market Comprehensive Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments -By Product (Medical Marijuana, Recreational marijuana), By Type (Oil, Tinctures, Flower)
In 2024, the marijuana market continues to evolve rapidly, driven by shifting attitudes towards cannabis legalization, medical research, and the burgeoning recreational and medicinal cannabis industry. Marijuana, also known as cannabis or weed, encompasses a variety of cannabis strains cultivated for their psychoactive effects, therapeutic properties, and industrial applications. With an increasing number of countries and states legalizing cannabis for medical and/or recreational use, the market has experienced exponential growth, attracting investment, innovation, and mainstream acceptance. From medical marijuana dispensaries offering cannabis-based treatments for chronic pain, anxiety, and other health conditions to recreational cannabis retailers providing a diverse array of products such as flower, edibles, concentrates, and topicals, the marijuana market offers something for everyone, from seasoned enthusiasts to curious newcomers. Moreover, the market is witnessing advancements in cannabis cultivation techniques, product formulations, and regulatory frameworks that aim to ensure quality, safety, and consistency across the supply chain. In 2024, the marijuana market is expected to continue expanding as cannabis legalization and normalization efforts gain momentum worldwide, offering new opportunities for entrepreneurs, investors, and consumers in the rapidly evolving cannabis landscape.
The market report analyses the leading companies in the industry including Bhang Inc, Botanic Lab, Cannabinoid Creations, Cannoid LLC, Canopy Growth Corp, CBD American Shaman LLC, CV Sciences Inc, Elixinol Wellness Ltd, Folium Biosciences, HEXO Corp, Jazz Pharmaceuticals Plc, Lexaria Bioscience Corp, MM Enterprises USA LLC, Organigram Holdings Inc, Unrivaled Brands Inc, and Others.
The ongoing trend of legalization and increasing acceptance of marijuana for both medical and recreational purposes is reshaping the market landscape. With more countries and states legalizing cannabis, the stigma surrounding its use is gradually diminishing. This trend is fueled by growing recognition of marijuana's potential therapeutic benefits in treating various medical conditions, such as chronic pain, epilepsy, and anxiety. As regulations evolve to accommodate legal cannabis markets, opportunities emerge for businesses to capitalize on the growing demand for marijuana products, ranging from pharmaceuticals to edibles and wellness products.
A significant driver for the marijuana market is its expanding applications in the medical and wellness sectors. As research continues to uncover the therapeutic properties of cannabinoids like CBD and THC, medical marijuana is gaining traction as a legitimate treatment option for a wide range of ailments. Moreover, the wellness industry is embracing cannabis-derived products for their potential to promote relaxation, alleviate stress, and improve overall well-being. This growing acceptance of marijuana as a natural remedy drives demand for various forms of cannabis-infused products, including oils, tinctures, topicals, and capsules, catering to health-conscious consumers seeking alternative therapies.
An opportunity for the marijuana market lies in diversifying and innovating product offerings to meet evolving consumer preferences and needs. With legalization opening doors to a broader consumer base, there is a demand for a wide array of cannabis products beyond traditional forms like dried flower and pre-rolled joints. Brands can capitalize on this opportunity by introducing innovative formats, such as cannabis-infused beverages, skincare products, pet supplements, and even cannabis-based pharmaceuticals. By leveraging technology and scientific advancements, companies can develop novel delivery methods, formulations, and dosage options to cater to diverse demographics and capture market share in this rapidly expanding industry.
In the marijuana market, the largest segment is medical marijuana, driven by its established legal frameworks, growing acceptance for medicinal purposes, and increasing demand for alternative healthcare options. Medical marijuana is utilized for various medical conditions, including chronic pain, epilepsy, multiple sclerosis, and chemotherapy-induced nausea, among others. Its therapeutic properties, such as pain relief, anti-inflammatory effects, and appetite stimulation, make it a preferred choice for patients seeking natural remedies. Additionally, the legalization of medical marijuana in many regions has led to the development of regulated dispensaries, clinics, and distribution networks, facilitating access to patients with medical prescriptions. Further, ongoing research and clinical trials continue to uncover new potential medical applications for marijuana, further bolstering the dominance of the medical marijuana segment in the market. As governments worldwide recognize the therapeutic benefits of marijuana and enact regulations to support its medical use, the medical marijuana segment continues to drive significant growth and market share within the marijuana industry.
Among the segments in the marijuana market, oil stands out as the fastest-growing, driven by its versatility, ease of use, and increasing consumer demand for alternative consumption methods. Marijuana oil, also known as cannabis oil or CBD oil, offers a convenient and discreet way to consume cannabinoids, such as THC and CBD, without the need for smoking or vaping. This appeals to consumers seeking health-conscious and smoke-free alternatives. Additionally, marijuana oil can be infused into various products, including edibles, beverages, topicals, and capsules, expanding its market reach and appeal. Further, the growing recognition of the therapeutic benefits of cannabinoids for various medical conditions, including chronic pain, anxiety, and insomnia, fuels the demand for marijuana oil as a natural remedy. As regulatory frameworks evolve to accommodate the legalization and regulation of marijuana products, the oil segment experiences rapid growth, positioning itself as a key driver of market expansion and innovation within the marijuana industry.
By Product
Medical Marijuana
Recreational marijuana
By Type
Oil
Tinctures
Flower
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Bhang Inc
Botanic Lab
Cannabinoid Creations
Cannoid LLC
Canopy Growth Corp
CBD American Shaman LLC
CV Sciences Inc
Elixinol Wellness Ltd
Folium Biosciences
HEXO Corp
Jazz Pharmaceuticals Plc
Lexaria Bioscience Corp
MM Enterprises USA LLC
Organigram Holdings Inc
Unrivaled Brands Inc
*- List Not Exhaustive
Chapter 1. TABLE OF CONTENTS
Chapter 2. Introduction to Marijuana Market
2.1. Market Overview
2.2. Key Statistics and Report Highlights
2.3. Scope of the Comprehensive Study
2.3.1. Market Definition
2.3.2 Countries and Regions Covered
2.3.3 Research Objective
2.3.4 Units, Currency, and Conversions
2.3.5 Industry Value Chain
2.4. Key Market Segments
2.5. Key Companies
2.6. Study Period
Chapter 3. Strategic Analysis Review
3.1. Marijuana Pricing Analysis and Forecast
3.2. Porter’s Five Forces
3.3. Market Ecosystem
3.4. SWOT Analysis
3.5. Regulatory Scenario
3.3. Effects of Inflation, Russia-Ukraine War, moderating economic growth, and other macroeconomic factors
Chapter 4. Competitive Landscape
4.1. Market Share Analysis
4.1.1. Global Marijuana Market Share by Company, 2023
4.1.2. Product Offerings of Leading Marijuana Companies
4.2. Market Entropy
4.2.1. New Product Launches in the Industry
4.2.2. Mergers, Acquisitions, Joint ventures, and Partnerships
4.3. Key Strategies and Best Practices
Chapter 5. Global Market Projections: Best, Reference, and Low Case Scenarios
5.1. Growth Analysis- Case Scenario Definitions
5.2. Low Growth Case Scenario Forecasts
5.3. Reference Growth Case Scenario Forecasts
5.4. High Growth Case Scenario Forecasts
Chapter 6. Market Dynamics
6.1. Marijuana Market Drivers
6.2. Marijuana Market Challenges
6.6. Marijuana Market Opportunities
6.4. Marijuana Market Trends
Chapter 7. Global Marijuana Market Outlook Trends
7.1. Global Marijuana Revenue (USD Million) and CAGR (%) by Type (2021-2032)
7.2. Global Marijuana Revenue (USD Million) and CAGR (%) by Application (2021-2032)
7.3. Global Marijuana Revenue (USD Million) and CAGR (%) by Product (2021-2032)
By Product
Medical Marijuana
Recreational marijuana
By Type
Oil
Tinctures
Flower
Chapter 8. Global Marijuana Regional Analysis and Outlook
8.1. Global Marijuana Revenue (USD Million) By Regions (2021- 2032)
8.2. North America Marijuana Revenue (USD Million) by Country (2021-2032)
8.2.1. United States Marijuana Regional Analysis and Outlook
8.2.2. Canada Marijuana Regional Analysis and Outlook
8.2.3. Mexico Marijuana Regional Analysis and Outlook
8.3. Europe Marijuana Revenue (USD Million), by Country (2021-2032)
8.3.1. Germany Marijuana Regional Analysis and Outlook
8.3.2. France Marijuana Regional Analysis and Outlook
8.3.3. United Kingdom Marijuana Regional Analysis and Outlook
8.3.4. Spain Marijuana Regional Analysis and Outlook
8.3.5. Italy Marijuana Regional Analysis and Outlook
8.3.6. Russia Marijuana Regional Analysis and Outlook
8.3.7. Rest of Europe Marijuana Regional Analysis and Outlook
8.4. Asia Pacific Marijuana Revenue (USD Million) by Country (2021-2032)
8.4.1. China Marijuana Regional Analysis and Outlook
8.4.2. Japan Marijuana Regional Analysis and Outlook
8.4.3. India Marijuana Regional Analysis and Outlook
8.4.4. South Korea Marijuana Regional Analysis and Outlook
8.4.5. Australia Marijuana Regional Analysis and Outlook
8.4.6. South East Asia Marijuana Regional Analysis and Outlook
8.4.7. Rest of Asia Pacific Marijuana Regional Analysis and Outlook
8.5. South America Marijuana Revenue (USD Million), by Country (2021-2032)
8.5.1. Brazil Marijuana Regional Analysis and Outlook
8.5.2. Argentina Marijuana Regional Analysis and Outlook
8.5.3. Rest of South America Marijuana Regional Analysis and Outlook
8.6. Middle East and Africa Marijuana Revenue (USD Million) by Country (2021-2032)
8.6.1. Middle East Marijuana Regional Analysis and Outlook
8.6.2. Africa Marijuana Regional Analysis and Outlook
Chapter 9. North America Marijuana Analysis and Outlook
9.1. North America Marijuana Revenue (USD Million) by Segments (2021-2032)
9.1.1. North America Marijuana Revenue (USD Million) by Type (2021-2032)
9.1.2. North America Marijuana Revenue (USD Million) by Application (2021-2032)
9.1.3. North America Marijuana Revenue (USD Million) by Product (2021-2032)
By Product
Medical Marijuana
Recreational marijuana
By Type
Oil
Tinctures
Flower
Chapter 10. Europe Marijuana Analysis and Outlook
10.1. Europe Marijuana Revenue (USD Million), by Segments (USD Million) (2021-2032)
10.1.1. Europe Marijuana Revenue (USD Million) by Type (2021-2032)
10.1.2. Europe Marijuana Revenue (USD Million) by Application (2021-2032)
10.1.3. Europe Marijuana Revenue (USD Million) by Product (2021-2032)
By Product
Medical Marijuana
Recreational marijuana
By Type
Oil
Tinctures
Flower
Chapter 11. Asia Pacific Marijuana Analysis and Outlook
11.1. Asia Pacific Marijuana Revenue (USD Million), and Revenue (USD Million) by Segments (2021-2032)
11.1.1. Asia Pacific Marijuana Revenue (USD Million) by Type (2021-2032)
11.1.2. Asia Pacific Marijuana Revenue (USD Million) by Application (2021-2032)
11.1.3. Asia Pacific Marijuana Revenue (USD Million) by Product (2021-2032)
By Product
Medical Marijuana
Recreational marijuana
By Type
Oil
Tinctures
Flower
Chapter 12. South America Marijuana Analysis and Outlook
12.1. South America Marijuana Revenue (USD Million), by Segments (2021-2032)
12.1.1. South America Marijuana Revenue (USD Million) by Type (2021-2032)
12.1.2. South America Marijuana Revenue (USD Million) by Application (2021-2032)
12.1.3. South America Marijuana Revenue (USD Million) by Product (2021-2032)
By Product
Medical Marijuana
Recreational marijuana
By Type
Oil
Tinctures
Flower
Chapter 13. Middle East and Africa Marijuana Analysis and Outlook
13.1. Middle East and Africa Marijuana Revenue (USD Million), by Segments (2021-2032)
13.1.1. Middle East and Africa Marijuana Revenue (USD Million) by Type (2021-2032)
13.1.2. Middle East and Africa Marijuana Revenue (USD Million) by Application (2021-2032)
13.1.3. Middle East and Africa Marijuana Revenue (USD Million) by Product (2021-2032)
By Product
Medical Marijuana
Recreational marijuana
By Type
Oil
Tinctures
Flower
Chapter 14. Marijuana Company Profiles
14.1 Business Overview
14.2 Product Profiles
14.3 SWOT Profiles
14.5 Recent Developments
14.6 Financial Profile
List of Companies
Bhang Inc
Botanic Lab
Cannabinoid Creations
Cannoid LLC
Canopy Growth Corp
CBD American Shaman LLC
CV Sciences Inc
Elixinol Wellness Ltd
Folium Biosciences
HEXO Corp
Jazz Pharmaceuticals Plc
Lexaria Bioscience Corp
MM Enterprises USA LLC
Organigram Holdings Inc
Unrivaled Brands Inc
15. Methodology and Data Sources
15.1 Customization Offerings
15.2 Subscription Services
15.3 Related Reports
15.4 Publisher Expertise
LIST OF TABLES
Table 1 Market Segmentation Analysis
Table 2 Global Marijuana Market Share of Leading Companies, 2023
Table 3 Product Offerings of Leading Companies
Table 4 Low Growth Scenario Forecasts
Table 5 Reference Case Growth Scenario
Table 6 High Growth Case Scenario
Table 7 Global Marijuana Revenue (USD Million) And CAGR (%) By Type (2021-2032)
Table 8 Global Marijuana Revenue (USD Million) And CAGR (%) By Application (2021-2032)
Table 9 Global Marijuana Revenue (USD Million) And CAGR (%) By Product (2021-2032)
Table 10 Global Marijuana Market Revenue (USD Million) By Regions (2021-2032)
Table 11 Global Marijuana Market Share (%) By Regions (2021-2032)
Table 12 North America Marijuana Revenue (USD Million) By Country (2021-2032)
Table 13 Europe Marijuana Revenue (USD Million) By Country (2021-2032)
Table 14 Asia Pacific Marijuana Revenue (USD Million) By Country (2021-2032)
Table 15 South America Marijuana Revenue (USD Million) By Country (2021-2032)
Table 16 Middle East and Africa Marijuana Revenue (USD Million) By Region (2021-2032)
Table 17 North America Marijuana Revenue (USD Million) By Type (2021-2032)
Table 18 North America Marijuana Revenue (USD Million) By Application (2021-2032)
Table 19 North America Marijuana Revenue (USD Million) By Product (2021-2032)
Table 20 Europe Marijuana Revenue (USD Million) By Type (2021-2032)
Table 21 Europe Marijuana Revenue (USD Million) By Application (2021-2032)
Table 22 Europe Marijuana Revenue (USD Million) By Product (2021-2032)
Table 23 Asia Pacific Marijuana Revenue (USD Million) By Type (2021-2032)
Table 24 Asia Pacific Marijuana Revenue (USD Million) By Application (2021-2032)
Table 25 Asia Pacific Marijuana Revenue (USD Million) By Product (2021-2032)
Table 26 South America Marijuana Revenue (USD Million) By Type (2021-2032)
Table 27 South America Marijuana Revenue (USD Million) By Application (2021-2032)
Table 28 South America Marijuana Revenue (USD Million) By Product (2021-2032)
Table 29 Middle East and Africa Marijuana Revenue (USD Million) By Type (2021-2032)
Table 30 Middle East and Africa Marijuana Revenue (USD Million) By Application (2021-2032)
Table 31 Middle East and Africa Marijuana Revenue (USD Million) By Product (2021-2032)
LIST OF FIGURES
Figure 1. Market Scope
Figure 2. Pricing Forecasts Per Unit, 2023- 2032
Figure 3. Porter’s Five Forces
Figure 4. Global Marijuana Market Revenue (USD Million) By Regions (2021-2032)
Figure 5. Global Marijuana Market Share (%) By Regions (2023)
Figure 6. North America Marijuana Revenue (USD Million) By Country (2021-2032)
Figure 7. United States Marijuana Revenue (USD Million) By Country (2021-2032)
Figure 8. Canada Marijuana Revenue (USD Million) By Country (2021-2032)
Figure 9. Mexico Marijuana Revenue (USD Million) By Country (2021-2032)
Figure 10. Europe Marijuana Revenue (USD Million) By Country (2021-2032)
Figure 11. Germany Marijuana Revenue (USD Million) By Country (2021-2032)
Figure 12. France Marijuana Revenue (USD Million) By Country (2021-2032)
Figure 13. United Kingdom Marijuana Revenue (USD Million) By Country (2021-2032)
Figure 14. Spain Marijuana Revenue (USD Million) By Country (2021-2032)
Figure 15. Italy Marijuana Revenue (USD Million) By Country (2021-2032)
Figure 16. Russia Marijuana Revenue (USD Million) By Country (2021-2032)
Figure 17. Rest of Europe Marijuana Revenue (USD Million) By Country (2021-2032)
Figure 11. Asia Pacific Marijuana Revenue (USD Million) By Country (2021-2032)
Figure 12. China Marijuana Revenue (USD Million) By Country (2021-2032)
Figure 13. Japan Marijuana Revenue (USD Million) By Country (2021-2032)
Figure 14. India Marijuana Revenue (USD Million) By Country (2021-2032)
Figure 15. South Korea Marijuana Revenue (USD Million) By Country (2021-2032)
Figure 16. Australia Marijuana Revenue (USD Million) By Country (2021-2032)
Figure 17. South East Asia Marijuana Revenue (USD Million) By Country (2021-2032)
Figure 18. South America Marijuana Revenue (USD Million) By Country (2021-2032)
Figure 19. Brazil Marijuana Revenue (USD Million) By Country (2021-2032)
Figure 20. Argentina Marijuana Revenue (USD Million) By Country (2021-2032)
Figure 21. Rest of Asia Pacific Marijuana Revenue (USD Million) By Country (2021-2032)
Figure 22. Middle East and Africa Marijuana Revenue (USD Million) By Region (2021-2032)
Figure 23. Saudi Arabia Marijuana Revenue (USD Million) By Region (2021-2032)
Figure 24. The UAE Marijuana Revenue (USD Million) By Region (2021-2032)
Figure 25. Rest of Middle East Marijuana Revenue (USD Million) By Region (2021-2032)
Figure 26. South Africa Marijuana Revenue (USD Million) By Region (2021-2032)
Figure 27. Africa Marijuana Revenue (USD Million) By Region (2021-2032)
Figure 28. North America Marijuana Revenue (USD Million) By Type (2021-2032)
Figure 29. North America Marijuana Revenue (USD Million) By Application (2021-2032)
Figure 30. North America Marijuana Revenue (USD Million) By Product (2021-2032)
Figure 31. Europe Marijuana Revenue (USD Million) By Type (2021-2032)
Figure 32. Europe Marijuana Revenue (USD Million) By Application (2021-2032)
Figure 33. Europe Marijuana Revenue (USD Million) By Product (2021-2032)
Figure 34. Asia Pacific Marijuana Revenue (USD Million) By Type (2021-2032)
Figure 35. Asia Pacific Marijuana Revenue (USD Million) By Application (2021-2032)
Figure 36. Asia Pacific Marijuana Revenue (USD Million) By Product (2021-2032)
Figure 37. South America Marijuana Revenue (USD Million) By Type (2021-2032)
Figure 38. South America Marijuana Revenue (USD Million) By Application (2021-2032)
Figure 39. South America Marijuana Revenue (USD Million) By Product (2021-2032)
Figure 40. Middle East and Africa Marijuana Revenue (USD Million) By Type (2021-2032)
Figure 41. Middle East and Africa Marijuana Revenue (USD Million) By Application (2021-2032)
Figure 42. Middle East and Africa Marijuana Revenue (USD Million) By Product (2021-2032)
By Product
Medical Marijuana
Recreational marijuana
By Type
Oil
Tinctures
Flower
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Global Marijuana Market Size is valued at $35.8 Billion in 2024 and is forecast to register a growth rate (CAGR) of 14.6% to reach $106.5 Billion by 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Bhang Inc, Botanic Lab, Cannabinoid Creations, Cannoid LLC, Canopy Growth Corp, CBD American Shaman LLC, CV Sciences Inc, Elixinol Wellness Ltd, Folium Biosciences, HEXO Corp, Jazz Pharmaceuticals Plc, Lexaria Bioscience Corp, MM Enterprises USA LLC, Organigram Holdings Inc, Unrivaled Brands Inc
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2032; Currency: Revenue (USD); Volume